ORIC Pharmaceuticals
ORIC Pharmaceuticals is a cancer, drug resistance founded in 2014 by Richard Heyman, Charles Sawyers and Scott Lowe.
3
Funding Rounds
$160.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ri***** He**** | - | - | |
| Sc*** Lo** | - | - | |
| Ch***** Sa***** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Ri***** He**** | - | - | |
| Ma*** C. Di** | - | - | |
| Lo** A. Ku**** | - | - | - |
| Ja*** Ch**** | - | - | |
| An*** Yo* | - | - | |
| St*** L. Ho***** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company ORIC Pharmaceuticals has raised a total of $160m in funding over 3 rounds.
Key Insights:
- ORIC Pharmaceuticals Series D round, August 2019: $55m
- ORIC Pharmaceuticals Series D round Funding Round 2019: $55m
- ORIC Pharmaceuticals Series C round, February 2018: $50m
ORIC Pharmaceuticals Series D round, August 2019
$55m
ORIC Pharmaceuticals Series D round Funding Round 2019
$55m
ORIC Pharmaceuticals Series C round, February 2018
$50m
Industries
ORIC Pharmaceuticals is active in the following industries: